By Jocelyn Aspa
The ransomware attacked computers in roughly 153 countries, igniting speculation that Microsoft is part to blame.
If you couldn’t attend the London event, never fear: today, we’re counting down the top three investor takeaways. It’s almost as good as being there.
Another pharmaceutical manufacturer is under scrutiny by US lawmakers: Reckitt Benckiser faces a lawsuit from some 35 states for its pricing of Suboxone.
Swedish Orphan Biovitrum today announces that the company’s product Alprolix®, a recombinant human factor IX Fc-fusion protein with extended half-life for the treatment of haemophilia B, has now been approved for reimbursement across the UK.
Groupe Athena, Inc. (OTCPINK:GATA) reported that they are in the final stages of negotiations with 2 Indian pharmaceutical companies for the manufacture of Atorvastatin, the generic form of Lipitor.